Skip to content
GCC AI Research

Probability and progress: statistics and AI in health care

MBZUAI · Notable

Summary

MBZUAI is hosting an "AI Quorum on Statistics for the Future of AI" in Abu Dhabi, focusing on the intersection of statistics and AI in healthcare. Organized by Professors Tian Zheng (Columbia University) and Hongtu Zhu (UNC), the event gathers experts from top global universities and organizations like Eli Lilly and MD Anderson Cancer Center. The workshop aims to integrate statistical insights into AI research, fostering innovations in the field. Why it matters: By convening international experts, MBZUAI is positioning itself as a hub for interdisciplinary AI research with a focus on healthcare applications.

Get the weekly digest

Top AI stories from the GCC region, every week.

Related

Data diagnostics: AI and statistics in computational biology and smart health

MBZUAI ·

MBZUAI's AI Quorum workshop featured Yale biostatistics professor Heping Zhang discussing the challenges of using AI and statistics to analyze noisy biological data for health insights. Zhang highlighted the need to develop methods to extract meaningful stories from noisy data to understand brain function and genetic roles in disease regulation. Harvard's Xihong Lin presented recommendations for building an ecosystem using AI and statistics to improve understanding of the relationship between genome sequences and biological functions. Why it matters: This discussion underscores the importance of AI and statistical methods in addressing the complexities of biological data, particularly in understanding neurological diseases like Alzheimer's, and highlights the need for centralized data infrastructure.

From Big Data to Bedside (DB2B): Artificial Intelligence in Precision Oncology

MBZUAI ·

This article discusses the use of artificial intelligence in precision oncology, particularly in understanding individual tumor mechanisms and aiding clinical decision-making. Dr. Xinghua Lu, with extensive experience in medicine and biomedical informatics, will present research on individualized Bayesian causal inference methods for investigating oncogenic mechanisms. These methods aim to provide clinical decision support at the cellular, tumor, and patient levels. Why it matters: AI-driven precision oncology can enable more personalized and effective cancer treatments, improving patient outcomes in the region and globally.

Towards Trustworthy AI: From High-dimensional Statistics to Causality

MBZUAI ·

Dr. Xinwei Sun from Microsoft Research Asia presented research on trustworthy AI, focusing on statistical learning with theoretical guarantees. The work covers methods for sparse recovery with false-discovery rate analysis and causal inference tools for robustness and explainability. Consistency and identifiability were addressed theoretically, with applications shown in medical imaging analysis. Why it matters: The research contributes to addressing key limitations of current AI models regarding explainability, reproducibility, robustness, and fairness, which are crucial for real-world applications in sensitive fields like healthcare.

Machine learning algorithms for precision medicine

MBZUAI ·

Agathe Guilloux, a professor in Data Science at Evry Paris Saclay University, presented on machine learning algorithms for precision medicine at MBZUAI. Her talk covered the main challenges of precision medicine and how AI can address them. She also discussed algorithms developed for decision support tools. Why it matters: This highlights MBZUAI's role as a platform for discussing advanced AI applications in healthcare, even when the research is not directly conducted in the GCC.